semaglutide ophthalmology The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of FDA data showed. Added GLP-1 Meds Reduce Risk of

A large body of research has demonstrated that ferroptosis is closely associated with the progression of gastrointestinal tumors (such as gastric cancer, colorectal cancer, and esophageal cancer), and gastrointestinal tumor cells exhibit unique sensitivity to ferroptosis

Patients often experience reduced hunger, early satiety, diminished cravings, more energy, and improved vitals like blood sugar levels, cholesterol, and blood pressure within weeks

Yes, mild burning or stinging at the injection site is a recognized adverse reaction that occurs in approximately 3.4% of patients

Understanding variants in GLP1R, GIPR, FTO, and MC4R helps predict not only efficacy but also tolerability, potentially preventing side-effect complications before they start

The treatment discontinuation proportions for 5 mg, 10 mg and 15 mg were 4.3%, 7.1% and 6.2%, respectively [18]